A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)
This study has been completed.
First Posted: April 1, 2008
Last Update Posted: April 4, 2017
Collaborative Study Group (CSG)
Information provided by (Responsible Party):